OverviewSuggest Edit

    BioKier is a clinical-stage medical food and pharmaceutical company developing oral products for people who are not able to manage their glucose. It offers mimicking product that improve or resolve diabetes in people undergoing the surgery for obesity. The product also helps in managing hypertriglyceridemia, metabolic syndrome, and obesity.

    Latest Updates

    Employees (est.) (May 2020)4
    Cybersecurity ratingBMore

    Key People/Management at BioKier

    Roger D. Nolan

    Roger D. Nolan

    Co-Founder, President and COO
    W. Bennett Love

    W. Bennett Love

    VP and Chief Financial Officer (Part-Time)
    Jerzy Szewczyk

    Jerzy Szewczyk

    Co-Founder, CEO and CSO
    Show more

    BioKier Financials and Metrics

    Summary Metrics

    Founding Date


    BioKier latest funding size

    $150 k
    Show all financial metrics

    BioKier Cybersecurity Score

    Cybersecurity ratingPremium dataset



    SecurityScorecard logo

    BioKier Online and Social Media Presence

    Embed Graph

    BioKier Blogs

    Completion of 4-week BKR-017 study in type 2 diabetes subjects and upcoming plans

    Despite significant delays related to COVID-19, in late 2020 BioKier completed a 4-week study of BKR-017 in type 2 diabetes subjects. Dr. Kishore Gadde’s team at Pennington Biomedical Research Center (PBRC) successfully recruited and enrolled 14 subjects in the study. All of those subjects completed…

    BioKier Frequently Asked Questions

    • When was BioKier founded?

      BioKier was founded in 2008.

    • Who are BioKier key executives?

      BioKier's key executives are Roger D. Nolan, W. Bennett Love and Jerzy Szewczyk.

    • How many employees does BioKier have?

      BioKier has 4 employees.

    • Who are BioKier competitors?

      Competitors of BioKier include Ember Therapeutics, Novaremed and Gan & Lee Pharmaceuticals.